Notably, Cx43 mutations that block MAPK phosphorylation sites significantly reduced Cx43 hemichannel activity and improved pathological outcomes in a stroke model, further supporting the importance of Cx43 phosphorylation in disease progression (49). The gene discussed is GJA1; the disease is Stroke.